Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,318 | 2,020 | 2,420 | 3,680 | 5,290 |
| Other current assets | 0 | 30 | 110 | 100 | 110 |
| TOTAL | $1,441 | $2,050 | $2,530 | $3,780 | $5,400 |
| Non-Current Assets | |||||
| PPE Net | 227 | 570 | 570 | 550 | 540 |
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $237 | $580 | $580 | $560 | $550 |
| Total Assets | $1,678 | $2,310 | $2,800 | $4,050 | $5,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 360 | 110 | 300 | 120 | 590 |
| TOTAL | $360 | $110 | $300 | $120 | $590 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $360 | $110 | $300 | $120 | $590 |
| Shareholders' Equity | |||||
| Common Shares | 28,360 | 28,190 | 27,260 | 27,360 | 27,200 |
| Retained earnings | -27,136 | -26,080 | -24,860 | -23,530 | -22,210 |
| Other shareholders' equity | 0 | 0 | 10 | 0 | 0 |
| TOTAL | $1,318 | $2,200 | $2,500 | $3,920 | $5,080 |
| Total Liabilities And Equity | $1,677 | $2,310 | $2,800 | $4,040 | $5,670 |